Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04775745 |
Title | Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies. |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Newave Pharmaceutical Inc |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Duke Univerisity | RECRUITING | Durham | North Carolina | 27708 | United States | Details |
University of Cincinnati | RECRUITING | Cincinnati | Ohio | 45221 | United States | Details |
Ohio State University | RECRUITING | Columbus | Ohio | 43210 | United States | Details |
Huntsman Cancer Institute, University of Utah | RECRUITING | Salt Lake City | Utah | 84112 | United States | Details |